Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFeeling persistently cold on Mounjaro is one of the more common (and more puzzling) things people notice after starting treatment. It has a straightforward biological explanation. As your body takes in fewer calories, it produces less heat; add a meaningful drop in body-fat insulation and the cold can feel relentless, especially in the first weeks. These are prescription-only medicines that require clinical assessment before you start, so if the sensation is severe or worrying you, speak to your prescriber rather than adjusting your dose yourself.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
NICE's appraisal of tirzepatide (TA1026, published December 2024) sits on a body of evidence that includes SURMOUNT-1, a 72-week trial in which participants lost an average of around 20–21% of body weight at the 15mg dose. That scale of change is metabolically significant. The body responds to sustained caloric reduction partly by dialling down thermogenesis: your core temperature and peripheral blood flow both fall a little, and cold feels sharper as a result. This is the same process documented in longer-term caloric restriction research; Mounjaro amplifies it because the appetite reduction it produces can be substantial.
The NHS tirzepatide medicines page lists common side effects as GI-led (nausea, diarrhoea, constipation) but cold sensitivity as a secondary consequence of weight loss and reduced food intake is a recognised pattern, and our page on tirzepatide and cold sensitivity explores why this happens in more detail. It is not listed as a direct pharmacological effect of tirzepatide, which matters: it means the cold is your body's adaptation, not an adverse drug reaction in the conventional sense.
Understanding that distinction is useful. It tells you the sensation is likely to shift as your weight stabilises, and it tells you what to expect at each dose stage rather than reading every cold spell as a warning sign.
Adipose tissue is a genuine insulator. Subcutaneous fat slows heat loss from the skin, and as that layer reduces, particularly across the hands, feet and limbs, people on Mounjaro often report feeling the cold in places that surprised them, cold hands in a warm room, needing an extra layer in summer. This is a real physical change, not a nocebo effect or anxiety about the medicine.
The timing typically tracks the speed of weight loss. For people who lose weight quickly in the first eight to twelve weeks (which can happen at the lower titration doses before the body has finished adjusting) the insulation loss can outpace adaptation. Some people find the intensity of cold sensitivity reduces after the first three or four months, once the rate of loss slows and the body's thermoregulatory mechanisms catch up. For others it remains a background feature throughout treatment.
If you're at the stage of wondering whether the cold you're feeling is normal, our dedicated page on feeling cold on Mounjaro covers the range of experiences people describe and what tends to drive them. It is rarely a clinical emergency, but it is also not something you should simply ignore if it is affecting your daily life, there are practical adjustments and, in some cases, clinical considerations worth raising at your next review. The full tirzepatide overview covers what to expect across the treatment arc.
One mechanism people rarely consider: eating generates heat. The thermic effect of food (the energy your body spends digesting and absorbing a meal) contributes meaningfully to your daily warmth, especially in the hours after eating. Mounjaro reduces appetite significantly and slows gastric emptying, which means both the volume of food arriving in your system and the speed at which nutrients become available are reduced. Less food in, less post-meal warmth out.
This is documented in the clinical pharmacology of tirzepatide: gastric emptying slows partly because GIP receptor activation changes gut motility alongside the GLP-1 pathway. You can read about this dual mechanism on the Mounjaro hub. The practical upshot is that people who previously ran warm after meals may find that warmth largely absent during treatment, particularly in the early months when appetite suppression is strongest.
Practical responses that have a physiological basis include eating adequate protein at each meal (protein has the highest thermic effect of any macronutrient), staying well hydrated, doing regular movement (which generates heat through muscle activity) and layering appropriately. None of those is a substitute for discussing persistent symptoms with your prescriber. Detailed personal advice on adapting to life on tirzepatide sits with the clinician who knows your full picture. You can explore the weight-loss treatment overview for a broader sense of what supervised treatment involves.
In most cases, if you find yourself always feeling cold on Mounjaro, it is a functional consequence of the very thing the medicine is doing: helping you eat less and lose weight. It is not a reason to stop treatment without clinical guidance, and it is not typically a sign of a medication reaction.
There are situations, though, where cold sensitivity warrants a proper clinical conversation. Hypothyroidism (underactive thyroid) can cause persistent cold intolerance and is sometimes identified in people who start to pay closer attention to their body during a weight-loss programme. If the cold is accompanied by unusual fatigue, hair thinning, slow heart rate, or puffy skin, thyroid function is worth checking with your GP. Iron-deficiency anaemia is another cause of cold intolerance that occasionally surfaces during significant dietary changes.
Neither of those possibilities means Mounjaro caused them, but the process of losing weight and eating differently sometimes prompts people to notice things they had attributed to other causes. The safest course if you are worried is to raise it at your next clinical review, and if you have broader questions about how the medicine performs it is also worth reading about whether Mounjaro always works and what can influence results. For questions about what your review covers or how our prescribers approach ongoing monitoring, the FAQs page is a good starting point, and if you want to reach the team directly the contact page is there. You can also read more about how we approach the clinical detail on the about us page.
If you are considering starting treatment and want to understand how the process works (from your first consultation through to what ongoing clinical support looks like) check your eligibility and start a free consultation with our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.